Suppr超能文献

消费者或医疗保健专业人员报告的关于儿童使用奥司他韦后出现异常行为的药品不良反应报告。

Adverse Drug Reaction Reports Regarding Abnormal Behavior After Oseltamivir Use in Children as Reported by Consumers or Healthcare Professionals.

作者信息

Noda Aoi, Tsuchiya Masami, Sakai Takamasa, Obara Taku, Mano Nariyasu

机构信息

Division of Preventive Medicine and Epidemiology, Tohoku University, Tohoku Medical Megabank Organization, Sendai, Miyagi, Japan.

Tohoku University Graduate School of Medicine, Sendai, Miyagi, Japan.

出版信息

Patient Prefer Adherence. 2021 Mar 4;15:533-541. doi: 10.2147/PPA.S292072. eCollection 2021.

Abstract

PURPOSE

The purpose of this study was to assess the differences between consumer (patient) and healthcare professional submissions of adverse drug reaction (ADR) reports associated with certain antiviral treatments in children.

MATERIAL AND METHODS

We extracted ADR reports for children aged <20 years who received oseltamivir or similar drugs (zanamivir and amantadine) between April 2004 and May 2020 from the Japanese Adverse Drug Event Report database. Abnormal behavior after oseltamivir administration was reported frequently in the news in November 2005, and a Dear Healthcare Professional letter about abnormal behavior after oseltamivir use was issued on March 20, 2007. We compared the number of ADR reports by three periods: (1) before the news, (2) between the news and the letter, and (3) after the letter. These reports were tabulated and analyzed after stratification according to the reporter (healthcare professionals only, patients and healthcare professionals, patients only), patient age (<10 years, 10-19 years), and ADR (abnormal behavior, other ADRs).

RESULTS

For the reports from healthcare professionals only, the number of reports per quarter associated with oseltamivir was largest during the period between the news about abnormal behavior after oseltamivir use and publication of the Dear Healthcare Professional letter. The reports from patients only about abnormal behavior after oseltamivir use were first reported after publication of the letter. The proportions of reports from patients only about abnormal behavior with oseltamivir were 81.0% and 92.2% for ages <10 and 10-19 years, respectively. A ripple effect of increasing reports was observed with zanamivir or amantadine.

CONCLUSION

Reports from patients only might increase in response to the media more than reports from healthcare professionals only or patients and healthcare professionals do. The ADR reports from patients must be carefully assessed from the perspective of when they were reported.

摘要

目的

本研究旨在评估消费者(患者)与医疗保健专业人员提交的与儿童某些抗病毒治疗相关的药物不良反应(ADR)报告之间的差异。

材料与方法

我们从日本药品不良反应事件报告数据库中提取了2004年4月至2020年5月期间接受奥司他韦或类似药物(扎那米韦和金刚烷胺)治疗的20岁以下儿童的ADR报告。2005年11月,新闻中频繁报道奥司他韦给药后出现异常行为,2007年3月20日发布了一封致医疗保健专业人员的信,内容涉及奥司他韦使用后的异常行为。我们比较了三个时间段的ADR报告数量:(1)新闻报道之前;(2)新闻报道与信件发布之间;(3)信件发布之后。这些报告在根据报告者(仅医疗保健专业人员、患者和医疗保健专业人员、仅患者)、患者年龄(<10岁、10 - 19岁)和ADR(异常行为、其他ADR)进行分层后进行列表和分析。

结果

对于仅来自医疗保健专业人员的报告,与奥司他韦相关的每季度报告数量在奥司他韦使用后异常行为的新闻报道至致医疗保健专业人员信件发布期间最多。仅患者关于奥司他韦使用后异常行为的报告在信件发布后首次出现。对于年龄<10岁和10 - 19岁的患者,仅关于奥司他韦异常行为的报告比例分别为81.0%和92.2%。观察到扎那米韦或金刚烷胺的报告有增加的连锁反应。

结论

仅患者的报告对媒体的反应可能比仅医疗保健专业人员的报告或患者与医疗保健专业人员的报告更强烈。必须从报告时间的角度仔细评估患者的ADR报告。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3a9d/7939497/b12eaa260ab6/PPA-15-533-g0001.jpg

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验